SCHEMBL5865845

SCHEMBL5865845

OC(c1ccc(Br)cc1)C(F)(F)C(O)c1ccc(Br)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA5A P35218 1/20 0.38
CA9 Q16790 1/20 0.38
CYP1A2 P05177 1/20 0.38
ALOX15 P16050 1/20 0.36
CFTR P13569 1/20 0.36
MAPK1 P28482 1/20 0.36
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
HTR2A P28223 1/20 0.34
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
CYP2C19 P33261 1/20 0.33
IDO1 P14902 1/20 0.33
ALOX5 P09917 1/20 0.33
IGF1R P08069 1/20 0.33
CNR1 P21554 1/20 0.33
SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1589426 0.86 ESR1 (0.39) CYP2A6CA1CA2CA5ACA9
SCHEMBL11685 0.86 ESR1 (0.39) CYP2A6CA1CA2CA5ACA9
SCHEMBL609900 0.86 ESR1 (0.39) CYP2A6CA1CA2CA5ACA9
SCHEMBL7961661 0.82 CA1 (0.35) CYP2A6CA1CA2CA5ACA9
SCHEMBL1589521 0.82 CYP1A2 (0.39) CYP2A6CA1CA2CA5ACA9
SCHEMBL2268223 0.76 CYP2A6 (0.50) CYP2A6CA1CA2CYP1A2ALOX15
SCHEMBL5865831 0.76 TSHR (0.44) CYP2A6ALOX15MAPK1IDO1
SCHEMBL3051159 0.76 CYP1A2 (0.42) CYP2A6CYP1A2ALOX15MAPK1HTR2A
SCHEMBL5865837 0.75 AOC3 (0.47) MAPK1CES2CES1
SCHEMBL12013619 0.74 CYP1A2 (0.41) CYP2A6CYP1A2ALOX15MAPK1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087789-B2 Methods for nucleophilic fluoromethylation UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2006-08-08 US claimed
US-20040230079-A1 Methods for nucleophilic fluoromethylation SOUTHERN CALIFORNIA, UNIVERSITY OF 2004-11-18 US claimed
WO-2004063129-A2 METHODS FOR NUCLEOPHILIC FLUOROMETHYLATION UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2004-07-29 WO claimed
US-7087789-B2 Methods for nucleophilic fluoromethylation UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2006-08-08 US disclosed
US-20040230079-A1 Methods for nucleophilic fluoromethylation SOUTHERN CALIFORNIA, UNIVERSITY OF 2004-11-18 US disclosed
WO-2004063129-A2 METHODS FOR NUCLEOPHILIC FLUOROMETHYLATION UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2004-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040230079-A1 Methods for nucleophilic fluoromethylation PHF2, HAO2, GSTM2 CYP2A6 988/4885CA1 288/4885CA2 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.